Not available
Quote | uniQure N.V. (NASDAQ:QURE)
Last: | $4.82 |
---|---|
Change Percent: | -0.64% |
Open: | $4.7 |
Close: | $4.82 |
High: | $4.87 |
Low: | $4.67 |
Volume: | 380,094 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | uniQure N.V. (NASDAQ:QURE)
2024-03-20 12:11:15 ET More on Kyowa Kirin Kyowa buyout Orchard wins FDA nod for rare disease therapy Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Read the full article on Seeking ...
~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington’s disease; Up to three years of follow-up data to be presented in mid-2024; Regulatory interactions and clarity on potential strategies for clinical development expected in 2024 ~ ...
Message Board Posts | uniQure N.V. (NASDAQ:QURE)
Subject | By | Source | When |
---|---|---|---|
Looks pretty positive | Thoro | investorshub | 06/20/2023 7:20:20 AM |
Do we have a winner?Turn around time? | Thoro | investorshub | 06/17/2023 8:50:17 AM |
$QURE Price gaining last trade up | Panzer | investorshub | 06/16/2023 8:49:55 PM |
and the shorts continue | Panzer | investorshub | 06/16/2023 2:50:25 AM |
$QURE MomentumIts trading up | Panzer | investorshub | 06/13/2023 1:23:30 AM |
News, Short Squeeze, Breakout and More Instantly...
uniQure N.V. Company Name:
QURE Stock Symbol:
NASDAQ Market:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter fin...
~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington's disease; Up to three years of follo...